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INTRODUCTION 
Inappropriate and irrational use of antimicrobial medicines 
provides favourable conditions for resistant 
microorganis ms to emerge, spread and persist. Infections 
caused by resistant microorganis ms often fail to respond to 
conventional treatment, resulting in prolonged illness and 
greater risk of death. Antimicrobial resistance (AMR) is 
resistance of a microorganism to an antimicrobial medicine 
to which it was previously sensitive. Resistant organisms 
(they include bacteria, viruses and some parasites) are able 
to withstand attack by antimicrobial medicines, such as 
antibiotics, antivirals, and antimalarials, so that standard 
treatments become ineffective and infections persist and 
may spread to others. AMR is a consequence of the use, 
particularly the misuse, of antimicrobial medicines and 
develops when a microorganism mutates or acquires a 
resistant gene. AMR reduces the effectiveness of treatment 
because patients remain infectious for longer, thus 
potentially spreading resistant microorganisms to others. 
The achievements of modern medicine are put at risk by 
AMR. Without effective antimicrobials for care and 
prevention of infections, the success of treatments such as 
organ transplantation, cancer chemotherapy and major 
surgery would be compromised
1
.
 
Quantitative structure activity relat ionship (QSAR) 
searches information relat ing chemical structure to 
biological and other activities by developing a QSAR 
model. Several molecular descriptors are used to quantify 
the structural feature of lead molecu le. The purpose of 
using QSAR-Descriptors is to calculate the properties of 
molecules that serve as numerical descriptions or 
characterizat ions of molecules in other calcu lations such as 
diversity analysis or combinatorial library design. Using 
such an approach one could predict the activities of newly  
designed compounds before a decision is being made 
whether these compounds should be really synthesized and 
tested. Recently, Cao H et al., have reported the 3D QSAR 
study on a series of thienopyrimidines as highly selective 
inhibitors of three receptor tyrosine kinases (RTKs)
2
. 
Singh M et al., have reported a novel QSAR model of a 
series of thienopyrimidine derivatives for evaluating and 
predicting the inhibit ion activity of H1-receptor 
antagonists
3
.  
Thienopyrimid ines and other fused pyrimidines continue 
to attract considerable attention of researchers in different 
countries because of their great practical usefulness, 
primarily, due to a wide spectrum of their biological 
activities.  Thienopyrimidines occupy a special position 
among these compounds. Along with some other 
pyrimidine systems containing an annelated five 
membered heteroaromatic ring, thienopyrimidines are 
structural analogs of biogenic purines and can be 
considered as potential nucleic acid antimetabolites
4
. 
Consequently, thienopyrimidines
5,6
 have become a well 
sought-privileged class of compounds in drug discovery 
programs due to their wide variety of interesting biological 
activities observed for these compounds, such as 
antimicrobial
7-11
, anticancer
12
, antiviral
13
, antitumor
14
 and 
anti-inflammatory activity
15
.  
In view of the above facts and scope a 2D-QSAR study is 
performed on structurally-related thienopyrimidine 
derivatives against a gram positive (S.aureus) and a gram 
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negative (E.coli) bacteria; in order to get a better 
understanding of their structural features and antibacterial 
activity. 
MATERIALS AND METHODS  
2D-QSAR methodology 
Data set 
Forty-three molecules belonging to thienopyrimidine 
derivatives as antibacterial were taken from the 
literature
8,9,16,17
 and used for QSAR analysis. The above 
reported series of thienopyrimidine derivatives showed 
wide variat ions in their structures and potency profiles. 
The 2D-QSAR models were generated for this series using 
multip le linear regression (MLR) and partial least squares 
(PLS) regression methods against S.aureus and E.coli and 
those models which come out with promising results are 
discussed here. QSAR models were generated by a train ing 
set of 34 molecules for each model. Predictive power of 
the resulting models was evaluated by a test set of 9 
molecules with uniformly distributed biological activit ies. 
The structures of all the compounds along with their actual 
and predicted biological activ ities are presented in Table 1.  
 
Table 1: Structure, Experimental and Predicted Activity of Thienopyrimid ines 
Sl.No. Structure 
pMIC
a  
(S.aureus) pMIC
a   
(E.coli)
 
Exp. Pred. Residual  Exp. Pred. Residual  
1 
N
N
S
NH2
NH  
3.29 3.47 -0.18 3.59 3.66 -0.07 
2 
N
NH
S
O  
3.29 3.37 -0.08 3.59 3.66 -0.07 
3 
N
N
S
H2N  
3.59 3.47 0.12 3.89 3.66 0.23 
4 
N
N
S O
NH
H2N
 
3.29 3.45 -0.16 3.59 3.62 -0.03 
5 
N
HN
S
O
O
 
3.29 3.34 -0.05 3.59 3.62 -0.03 
6 
N
N
S O
NH2
 
3.59 3.45 0.14 3.59 3.62 -0.03 
7 N
N
N
N
S
 
3.59 3.80 -0.21 3.59 3.70 -0.11 
8 
N
N
N
N
S
 
3.89 3.85 0.04 3.59
T
 3.78 -0.19 
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9 
N
N
N
N
S
 
3.89 3.90 -0.01 3.59
 
 3.86 -0.27 
10 N
N
N
N
S
O
 
3.89 3.78 0.11 3.89 3.66 0.23 
11 
N
N
N
N
S
O
 
3.59
T 
3.83 -0.24 3.89
T
 3.74 0.15 
12 
N
N
N
N
S
O
 
3.89 3.88 0.01 3.59 3.82 -0.23 
13 
S N
N
O
S
N
CH3
 
5.0 4.51 0.49 4.0 4.55 -0.55 
14 
S N
N
O
S
N
CH3
CH3
 
4.0
T
 4.54 -0.54 4.22
T
 4.59 -0.37 
15 
S N
N
O
S
N
Cl
Cl
 
4.0 4.49 -0.49 4.0 4.51 -0.51 
16 
S N
N
O
S
N
 
4.22
T
 4.49 -0.27 4.0 4.51 -0.51 
17 
S
N
N
O
S
N
NO2
 
4.0 3.99 0.01 4.0
T
 4.51 -0.51 
18 
S N
N
O
S
N CH
2
 
4.0 4.51 -0.51 4.09 4.55 -0.46 
19 
S N
N
O
S
N
C2H5
 
4.0
T
 4.34 -0.34 4.09
T
 4.27 -0.18 
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20 
S N
N
O
S
N
 
5.0 4.39 0.61 5.0 4.35 0.65 
21 
S N
N
O
S
N
CH3
 
5.0
T
 4.31 0.69 5.0
T
 4.23 0.77 
22 
NH
N
S
O
S
OHHO
ONH2  
4.22 4.05 0.17 4.09 4.12 -0.03 
23 
N
N
S
O
S
N
Cl
O
NH2
 
4.09 4.44 -0.35 4.0 4.08 -0.08 
24 N
N
S
O
S
O
NH2
 
4.90 4.26 0.64 4.0 4.12 -0.12 
25 
N
N
S
O
S
Cl
ONH2  
4.0 4.26 -0.26 4.0 4.12 -0.12 
26 N
N
S
O
S
O
O
ONH2  
5.20
T
 4.31 0.89 4.90
T
 4.20 0.7 
27 
N
N
S
O
S
O
ONH2  
4.0 4.28 -0.28 4.0 4.16 -0.16 
28 
N
N
S
O
NH2
 
4.90
T
 4.11 0.79 4.90 4.23 0.67 
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29 
S
N
N
CH3
N
O
Cl  
5.0 4.88 0.12 5.20 4.71 0.49 
30 
S
N
N
CH3
N
O OCH3
OCH3
OCH3
 
5.0 4.61 0.39 4.90 4.71 0.19 
31 
S
N
N
CH3
N
O
HO
OCH3
 
4.30 4.61 -0.31 4.90 4.36 0.54 
32 
S
N
N
C2H5
N
O OCH3
 
5.0 4.79 0.21 5.0 4.98 0.02 
33 
S
N
N
C2H5
N
O
N
H3C
H3C
 
5.0 4.87 0.13 5.0 4.94 0.06 
34 
S
N
N
C2H5
N
O
Cl
Cl
Cl  
4.69 4.98 -0.29 5.0 4.86 0.14 
35 
S
N
N
C2H5
N
O N
 
5.0 5.02 -0.02 4.90 5.02 -0.12 
36 
S N
N
NN
O
 
4.19 4.48 -0.29 4.49 4.61 -0.12 
37 
S N
N
NN
 
4.49
T
 4.43 0.06 4.49
T
 4.53 -0.04 
Khazi et al                                  Journal of Drug Delivery & Therapeutics; 2012, 2(2)   60 
 
 
© 2011, JDDT. All Rights Reserved                                                                                                                                                      ISSN: 2250-1177 
38 
S N
N
NN
Cl
 
4.79 4.69 0.1 4.49 4.09 0.4 
39 
S
N
N
NN
 
4.49 4.18 0.31 4.49 4.13 0.36 
40 
S N
N
NN
 
4.49 4.31 0.18 4.49 4.33 0.16 
41 
S N
N
NN
S
 
4.19
T
 4.13 0.06 4.49
 
 4.05 0.44 
42 
S N
N
NN
 
4.49 4.51 -0.02 4.49 4.64 -0.15 
43 
S N
N
NN
O
 
5.39 5.46 -0.07 4.79
T
 4.97 -0.18 
 
Expt. = Experimental activity; Pred. = Predicted activity;  a = -Log (MICx10-6); T = Test Set 
 
Biological activities 
The biological activ ities (MIC) were converted into the 
corresponding pMIC values  (Eq. 1), where MIC value 
represents the lowest concentration of drug in microgram 
that inhibited the visible growth of a microorganism after 
overnight incubation. The MIC values of reference 
compounds were checked to ensure that no difference 
occurred between different groups. The pMIC values of 
the molecules under study spanned a range from 3.29-5.39 
and 3.59-5.20 for S.aureus and E.coli, respectively.  
pMIC =  – log(MIC x 10
-6
) ….. Eq. (1) 
 
Computational data 
The antibacterial activ ity data used for the QSAR analys is 
contains 43 molecu les belonging to thienopyrimidine 
derivatives. All the structures of the compounds were 
drawn in 2D-APPL mode of software. The modeling 
analyses, calculations, and visualizat ions for 2D-QSAR 
were performed using the V-Life Molecu lar Design Suite 
3.5 (Vlife MDS 3.5). The compounds were then subjected 
to conformational analysis and energy minimization using 
Montocarlo conformational search with RMS gradient of 
0.001 kcal/mol using a MMFF force field. Montocarlo 
conformat ional search method is similar to the RIPS 
method that generates a new molecular conformat ion by 
randomly perturbing the position of each coordinate of 
each atom in molecule. Most stable structure for each 
compound was generated after energy min imization and 
used for calcu lating various physicochemical descriptors. 
Molecular descriptors 
The various descriptors selected for 2D QSAR were 
Individual, Retention Index (ch i), Atomic valence 
connectivity index (chiv), Path Count, Cluster, Kappa.  
Selection of training and test set 
In order to obtain a validated QSAR model for the purpose 
of meaningful predict ion, an available dataset should be 
divided into the training and test sets. For the prediction 
statistics to be reliable, the test set must include at least 
five compounds
18
. Ideally, the division into the train ing 
and test set must satisfy the following three conditions: (i) 
All representative compound-points of the test set in the 
multid imensional descriptor space must be close to those 
of the training set. (ii) All representative points of the 
training set must be close to those of the test set. (iii) The 
representative points of the training set must be distributed 
within the whole area occupied by the entire dataset
18
. 
Khazi et al                                  Journal of Drug Delivery & Therapeutics; 2012, 2(2)   61 
 
 
© 2011, JDDT. All Rights Reserved                                                                                                                                                      ISSN: 2250-1177 
The dataset of 43 molecules was divided into training and 
test sets by sphere exclusion (SE) method for MLR and 
PLS model using pMIC activity field as dependent 
variable and various 2D descriptors as independent 
variables. In classical sphere exclusion algorithm the 
molecules are selected whose similarities with each of the 
other selected molecules are not higher than a defined 
threshold
19
. Each selected molecule generates a hyper- 
sphere around it, so that any molecule inside the sphere is 
excluded from the selection in the train set and driven 
towards the test set. The number of compounds selected 
and the diversity among them can be determined by 
adjusting the radius of the sphere (R). The different 
statistical models were developed using multiple linear 
regression (MLR) and partial least squares (PLS) 
regression methods. The equations were found to derive 
2D-QSAR equation from different model building method 
(MLR and PLS) coupled with stepwise forward–backward  
variable select ion method for assuming the biological 
activity with the help of physico-chemical descriptor 
values. The equations are discussed in Section 3 which  
come out with promising results from MLR and PLS.  
Statistical parameters 
Statistical measures used for the evaluation of models were 
the number of compounds in regression n, the regression 
coefficient r
2
, the F-test (Fischer’s value) for statistical 
significance F, the cross-validated correlation coefficient 
q
2
 and the standard error of estimat ion r
2
 and q
2
. The 
regression coefficient r
2
 is a relative measure of fit by the 
regression equation. It represents the part of the variation 
in the observed data that is explained by the regression. 
The correlation coefficient values closer to 1.0 represent 
the better fit of the regression. The F-test reflects the ratio 
of the variance exp lained by the model and the variance 
due to the error in the regression. High values of the F-test 
indicate that the model is statistically significant. 
Validation parameter, predictive r
2
(r
2
_pred) was calculated 
for evaluating the predictive capacity of the model. A  
value of r
2
_pred greater than 0.5 indicates the good 
predictive capacity of the QSAR model.  
Model validation 
This is done to test the internal stability and predictive 
ability of the QSAR models. Developed QSAR models 
were validated by the following procedure.  
Internal validation  
Internal validation was carried out using leave-one-out (q
2
, 
LOO) method. For calculat ing q
2
, each molecule in the 
training set was eliminated once and the activity of the 
eliminated molecule was predicted by using the model 
developed by the remain ing molecu les. The q
2
 was 
calculated using the equation (Eq. 2) which describes the 
internal stability of a model.  
q
2 
= 1– 
∑(yi – ŷi)
2 
….. Eq. (2) 
∑(yi – ymean)
2
 
 
where yi and ŷi are the actual and predicted activity of the 
ith molecule in the training set, respectively, and ymean is 
the average activity of all molecules in the train ing set. 
External validation 
The predictive ability of the selected model was also 
confirmed by external validation of test set compounds 
which is also denoted with pred_r
2
. The pred_r
2
 value is 
calculated as follows (Eq. 3): 
Pred_r
2 
= 1– 
∑(yi – ŷi)
2 
….. Eq. (3) 
∑(yi – ymean)
2
 
where yi and ŷi are the actual and predicted activity of the 
ith molecule in the training set, respectively, and ymean is 
the average activity of all molecules in the train ing set. 
Randomization test 
To evaluate the statistical significance of the QSAR model 
for an actual dataset, one-tail hypothesis testing was 
used
20
.The robustness of the models for training sets was 
examined by comparing these models to those derived for 
random datasets. Random sets were generated by 
rearranging the activities of the molecules in the train ing 
set. The statistical model was derived using various 
randomly  rearranged activities (random sets) with the 
selected descriptors and the corresponding q
2
 were 
calculated. The significance of the models hence obtained 
was derived based on a calculated Z score
21
. A Z score 
value is calculated by the following formula (Eq . 4): 
Z score =  
(h – μ) 
….. Eq. (4) 
σ 
where h is the q
2
 value calculated for the actual dataset, μ 
the average q
2
, and σ is its standard deviation calculated 
for various iterations using models built by different 
random datasets. 
QSAR by Multiple Linear Regression (MLR) Analysis 
Multiple regression is the standard method for mult ivariate 
data analysis. It is also called as ordinary least squares 
regression (OLS). This method of regression estimates the 
values of the regression coefficients by applying least 
squares curve fitting method. For getting reliable results, 
dataset having typically 5 times as many data points 
(molecules) as independent variables (descriptors) is 
required. 
The regression equation takes the form 
Y = b1*x1 + b2*x2 + b3*x3 + c ….. Eq. (5) 
Where, Y is the dependent variable, the ‘b’s are regression 
coefficients for corresponding ‘x’s (independent  variable), 
‘c’ is a regression constant or intercept. In the present 
study QSAR model was developed using mult iple  
regression by forward-backward variab le selection method 
with pMIC activ ity field as dependent variable and 
physicochemical descriptors as independent variable 
having cross correlation limit of 20 and number of 
variables in final equation were 5 and 3 for S.aureus and 
E.coli respectively. Selection of test and training set was 
done by sphere exclusion method. 
QSAR by Partial Least Squares (PLS) Regression 
Method 
PLS is an effective technique for finding the relationship  
between the properties of a molecu le and its structure. In  
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mathematical terms, PLS relates a matrix Y of dependent 
variables to a matrix X of molecular structure descriptors, 
i.e., a latent variable approach to modeling the covariance 
structures in these two spaces. PLS have two objectives: to 
approximate the X and Y data matrices, and to maximize  
the correlation between them. Whereas the extraction of 
PLS components is performed stepwise and the importance 
of a single component is assessed independently, a 
regression equation relating each Y variable with the X 
matrix is created. PLS decomposes the matrix X into 
several latent variables that correlate best with the activity  
of the molecules. PLS can be done using NIPALS or  
SIMPLS iterat ive algorithm, with consecutive estimates  
obtained using the residuals from previous iterations as the 
new dependent variable  
The regression equation takes the form 
Y = b0 + b1X1 + b2X2 + ... + bpXp …… Eq. (6)  
In this equation b0 is the regression coefficient for the 
intercept and the bi values are the regression coefficients 
(for variables 1 through p) computed from the data. 
The QSAR model was developed using partial least  
squares by forward-backward variab le selection method 
with pMIC activ ity field as dependent variable and 
physicochemical descriptors as independent variable 
having cross correlation limit of 20 and number of 
variables in final equation were 3 each for S.aureus and 
E.coli. Select ion of test and training set was done by 
sphere exclusion method. 
RES ULT AND DISCUSSION 
With regard to QSAR modeling, our first goal was to 
establish a predictive model with a reasonable number of 
input features to ensure good generalization performance. 
While correlating various descriptors with biological 
activity is the most important means to study structure–
activity relationships, the interest lies in deciding when to 
stop adding a new descriptor to the model. Thus, the 
optimal model should use the min imum number of 
descriptors to obtain the best fit.  
Train ing set of 34 and 09 of test set of thienopyrimidines 
having different substitution, were employed. The 2D-
QSAR models were developed separately for S.aureus and 
E.coli. Following statistical measure was used to correlate 
biological activ ity and molecular descriptors; n ,number of 
molecules; k ,number of descriptors in a model; df ,degree 
of freedom; r
2
 ,coefficient of determination; q
2
 , cross 
validated r
2
; pred_r
2
 , r
2
 for external test set; pred_r
2
se , 
coefficient of correlation of predicted data set; Z score, Z 
score calculated by the randomization test; 
best_ran_r
2
;best_ran_q
2
,highest q
2
 value in the 
randomizat ion test; α, statistical significance parameter 
obtained by the randomization test. 
Generation of QSAR Models  
Model– 1 (Multiple Linear Regression (MLR) Analysis) 
After 2D QSAR study by Multiple Linear Regression 
method using forward-backward stepwise variable 
selection method, the final QSAR equation was developed 
having 5 variab les as follows. 
pMIC (S.aureus) = + 0.0251(± 0.0010) T_C_C_7 + 0.6640(± 
0.0982) T_N_O_3 + 0.1022(± 0.0167) T_2_N_1 - 0.3491(± 
0.1583) T_N_O_1 + 0.2680(± 0.1309) T_N_Cl_4 + 2.9396 
Model – 1 has a correlation coefficient (r2) of 0.9849, 
significant cross validated correlation coefficient (q
2
) of 
0.8881, F test of 40.4301 and degree of freedom 28. The 
model is validated by α_ran_r2 = 0.0000, α_ran_q2 = 
0.0000, best_ran_r
2
 = 0.29216, best_ran_q
2
 = 0.03433, Z 
score_ran_r
2
 = 7.94639 and Z score_ran_q
2
 = 8.71551. The 
randomizat ion test suggests that the developed model have 
a probability of less than 1% that the model is generated by 
chance. The observed and predicted pMIC along with 
residual values are shown in Table 1. Statistical data is 
shown in Table 2. The plot of observed vs. predicted 
activity is shown in Figure 1.  According to this Model 1, 
the alignment independent descriptors like T_C_C_7, 
T_N_O_3, T_2_N_1 and T_N_Cl_4 are directly; whereas 
T_N_O_1 is ind irectly proportional to the antibacterial 
activity against S.aureus and explains the importance of 
aromat icity in antibacterial act ivity. The descriptors which 
contribute for the pharmacological act ion are shown in 
Table 3 and Figure 2. 
After 2D QSAR study by Multiple Linear Regression 
method using forward-backward stepwise variable 
selection method, the final QSAR equation was developed 
having 3 variab les as follows. 
pMIC (E.coli) = + 0.0394(± 0.0011) T_C_C_7 + 0.4560(± 
0.1252) T_N_O_3 - 0.3499(± 0.1635) T_O_O_7 + 3.6257 
Model – 1 has a correlation coefficient (r2) of 0.8719, 
significant cross validated correlation coefficient (q
2
) of 
0.7811, F test of 40.4768 and degree of freedom 30. The 
model is validated by α_ran_r2 = 0.0000, α_ran_q2 = 
0.0000, best_ran_r
2
 = 0.23848, best_ran_q
2
 = 0.03342, Z 
score_ran_r
2
 = 7.65114 and Z score_ran_q
2
 = 8.54198. The 
randomizat ion test suggests that the developed model have 
a probability of less than 1% that the model is generated by 
chance. The observed and predicted pMIC along with 
residual values are shown in Table 1. Statistical data is 
shown in Table 2.The p lot of observed vs. predicted 
activity is shown in Figure 3.  Along with the alignment 
independent descriptors like T_C_C_7 and T_N_O_3 are 
directly; whereas T_O_O_7 is directly proportional to the 
antibacterial activ ity against E.coli. The percentage 
contribution of these descriptors is given in Table 3 and 
Figure 4. 
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Table 2: Statistical parameters of MLR and PLS 
Parameters S.aureus E.coli 
 MLR PLS MLR PLS 
N 34 34 34 34 
Df 28 32 30 31 
r
2
 0.9849 0.7051 0.8719 0.6710  
q
2
 0.8881 0.6574 0.7811 0.5883 
F test  40.4301 33.5104 40.4768 31.6084 
r
2
 se 0.7058 0.3350 0.6269  0.3220 
q
2
 se 0.8682 0.3610 0.7693 0.3602 
pred_r
2
 0.6342 0.5287 0.6195 0.5158 
best_ran_r
2
 0.29216 0.21576 0.23848 0.18480 
best_ran_q
2
 0.03433 0.02140 0.03342 0.01996 
Z score_ran_r
2
 7.94639 6.45317 7.65114 6.07437 
Z score_ran_q
2
 8.71551 8.68220 8.54198 8.19551 
α_ran_r2 0.0000 0.0000 0.0000 0.00000 
α_ran_q2 0.0000 0.0000 0.0000 0.00000 
Z score_pred_r
2 
0.55371 0.48822 0.43250 0.39181 
Best_ran_Pred_r
2
 0.42210 0.32077 0.23959  0.24636 
α_ran_pred_r2 0.0000 0.0000 0.00000 0.00000 
 
MLR = multiple linear regression, PLS = partial least squares, N = number of molecules of training set, Df= degree of freedom, r2 = 
coefficient of determination, q2 =cross-validated r2, pred_r2= r2 for external test set, Z score = the Z score calculated by q2 in the 
randomization test, best_ran_q2 = the highest q2 value in the randomization test and a_ran_q2 =the statistical significance parameter 
obtained by the randomization test.  
 
. 
 
Table 3: Molecular descriptors contributing in the present study 
Descriptor Description 
Alignment independent descriptors 
 
T_C_C_7  This is the count of number of carbon atoms separated from carbon  atoms by 
seven bond distance 
T_N_O_3  This is the count of number of nitrogen atoms separated from oxygen  atoms by 
three bond distance 
T_2_N_1  This is the count of number of double bonded atoms separated from n itrogen 
atoms by  a single  bond distance 
T_N_O_1 This is the count of number of nitrogen atoms separated from oxygen atom by  
single bond distance 
T_O_O_7 This is the count of number of oxygen atoms separated from oxygen atoms by 
seven bond distance 
T_N_Cl_4  This is the count of number of nitrogen atoms separated from chlorine atoms by 
four bond distance 
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Figure 1: Graph of Actual vs. Predicted activit ies for 
training and test set molecules from the Multip le Linear 
Regression (MLR) model. (A) Training set (Red dots) 
(B) Test Set (Blue dots) (S.aureus) 
 
Figure 3: Graph of Actual vs. Predicted activit ies for 
training and test set molecules from the Multip le Linear 
Regression (MLR) model. (A) Training set (Red dots) 
(B) Test Set (Blue dots) (E.coli) 
 
Figure 2: Plot of percentage contribution of each 
descriptor in developed MLR model explaining variation 
in the activity (S.aureus). 
 
 
 
 
Figure 4: Plot of percentage contribution of each 
descriptor in developed MLR model explaining variation 
in the activity (E.coli)
Model – 2 (Partial Least S quares (PLS) Analysis) 
Model - 2 is having following QSAR equation with 3 
variables. 
pMIC (S.aureus) = + 0.0383 T_C_C_7 + 0.4863 T_N_O_3 
+ 0.0689 T_2_N_1 + 3.1226 
The Model -2 gave correlation coefficient (r
2
) of 0.7051, 
significant cross validated correlation coefficient (q
2
) of 
0.6574, F test of 33.5104 and degree of freedom 32. The 
model is validated by α_ran_r2 = 0.0000, α_ran_q2 = 
0.0000, best_ran_r
2
 = 0.21576, best_ran_q
2
 = 0.02140, Z 
score_ran_r
2
 = 6.45317 and Z score_ran_q
2
 = 8.68220. The 
randomizat ion test suggests that the developed model have 
a probability of less than 1% that the model is generated by 
chance. The observed and predicted pMIC along with 
residual values are shown in Table 1. Statistical data is 
shown in Table 2. The plot of observed vs. predicted 
activity is shown in Figure 5. According to Model 2, the 
antibacterial act ivity of thienopyrimidine derivatives 
against S.aureus is mainly attributed to the alignment 
independent descriptors like T_C_C_7, T_N_O_3 and 
T_2_N_1; this clearly signifies the importance of 
aromat icity in antibacterial act ivity. The descriptors which 
contribute for the pharmacological act ion are shown in 
Table 3 and Figure 6. 
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Model - 2 is having following QSAR equation with 3 
variables. 
pMIC (E.coli) = + 0.0385 T_C_C_7 + 0.3497 T_N_O_3 + 
0.3186 T_N_Cl_4 + 3.5918 
The model -2 gave correlation coefficient (r
2
) o f 0.6710, 
significant cross validated correlation coefficient (q
2
) of 
0.5883, F test of 31.6084 and degree of freedom 31. The 
model is validated by α_ran_r2 = 0.0000, α_ran_q2 = 
0.0000, best_ran_r
2
 = 0.18480, best_ran_q
2
 = 0.01996, Z 
score_ran_r
2
 = 6.07437 and Z score_ran_q
2
 = 8.19551. The 
randomizat ion test suggests that the developed model have 
a probability of less than 1% that the model is generated by 
chance. The observed and predicted pMIC along with 
residual values are shown in Table 1. Statistical data is 
shown in Table 2. The plot of observed vs. predicted 
activity is shown in Figure 7.  The alignment independent 
descriptor like T_C_C_7, T_N_O_3 and T_N_Cl_4 are 
directly proportional to the antibacterial activ ity. The 
descriptors which contribute for the pharmacological 
action are shown in Table 3 and Figure 8.  
 
 
Figure 5: Graph of Actual vs. Predicted activit ies for 
training and test set molecules from the Partial Least 
Squares (PLS) model. (A) Training set (Red dots) (B) 
Test Set (Blue dots) (S.aureus) 
 
 
Figure 7: Graph of Actual vs. Predicted activit ies for 
training and test set molecules from the Partial Least 
Squares (PLS) model. (A) Training set (Red dots) (B) 
Test Set (Blue dots) (E.coli) 
 
 
Figure 6: Plot of percentage contribution of each 
descriptor in developed PLS model exp lain ing variation in 
the activity (S.aureus) 
 
 
Figure 8: Plot of percentage contribution of each 
descriptor in developed PLS model exp lain ing variation in 
the activity (E.coli) 
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The above study leads to the development of statistically  
significant QSAR model, which allows understanding of 
the molecular properties/features that play an important 
role in governing the variation in the activities. In addition, 
this QSAR study allowed investigating influence of very  
simple and easy-to-compute descriptors in determin ing 
biological activit ies, which could shed light on the key 
factors that may aid in design of novel potent molecules. 
CONCLUS ION 
In conclusion, the 2D-QSAR models developed to predict 
the structural features of thienopyrimidines to inhibit  the 
growth of S.aureus (gram positive) and E.coli (gram 
negative), reveals useful information about the structural 
features requirement for the molecu le. In all the optimized  
models, MLR method has given very significant results 
both in S.aureus and E.coli. This model could be 
considered as best one in terms of excellent internal and 
external predict ive abilities. According to model I and II, 
the alignment independent descriptors help in 
understanding the effect of substituent at different position 
of thienopyrimid ine derivatives. The results obtained from 
this 2D-QSAR study are in agreement with the observed 
SAR of thienopyrimidine studied. Hence, the model 
proposed in this work is useful and can be employed to 
design new derivatives of thienopyrimid ines as prospective 
antibacterial agents.  
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